DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastric Cancer

Clinical trial NCT07757191 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07757191
Sponsor: Taipei Veterans General Hospital, Taiwan
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Gasrtic Cancer

Start date: 2026-09-01
Primary completion: 2028-09-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.